Only 25 percent of post-acute patients with Afib start anticoagulants: study
By
Alicia Lasek
Apr 24, 2023
Rates of anticoagulation therapy were higher for patients whose main reason for acute-care admission was Afib, yet only 50% of those patients initiated use.
Aspirin as good as heparin at preventing blood clots after fracture surgery: study
By
Alicia Lasek
Jan 19, 2023
The findings could having an impact on clinical practice and even alter the standard of care, say the authors of a study published Wednesday in the New England Journal of Medicine.
Risk of blood clots remains almost a year after COVID-19
By
Lori Baker
Sep 22, 2022
A large, new study published by the American Heart Association reveals the threat of blood clots leading to life-threatening strokes, heart attacks and pulmonary embolism can linger for nearly a year after...
Newer blood thinners surpass warfarin for treating seniors with Afib and prior stroke
By
Alicia Lasek
Apr 14, 2022
Direct oral anticoagulants are linked to fewer readmissions for stroke and bleeding events when compared with warfarin, investigators say.
Clinical briefs for Friday, Feb. 11
By
Alicia Lasek
Feb 11, 2022
CDC considers updating mask guidance as states drop mandates … Clot-busting stroke drug safe to use in patients taking blood thinners … New questionnaire helps assess elders’ exercise motivation...
Clinician ‘inertia’? Many still favoring warfarin over safer direct-acting anticoagulants
By
Alicia Lasek
Dec 07, 2021
Many clinicians participating in the Medicare Part D program have continued to prescribe warfarin over direct-acting oral anticoagulants, despite evidence that the latter drugs are safer and more effective...
Low-dose aspirin does not reduce adverse heart, lung outcomes in stable COVID patients: study
By
Alicia Lasek
Oct 19, 2021
Contrary to some clinical observations, aspirin and apixaban (Eliquis) do not reduce the rate of major adverse cardiovascular or pulmonary outcomes in stable outpatients with symptomatic COVID-19, researchers...
Heparin emerging as a lifesaver for moderately ill COVID patients
By
Alicia Lasek
Oct 18, 2021
High doses of the anticoagulant reduce the risk of developing the dangerous blood clots that are a hallmark of COVID-19, two new studies confirm.
Anticoagulants tied to 43 percent lower risk of COVID hospitalization
By
Alicia Lasek
Sep 29, 2021
Patients who take anticoagulants before contracting COVID-19 are 43% less likely to be admitted to the hospital, and those who are given the drugs while hospitalized are less likely to die, according to...
Docs miss — or opt to dismiss — signs of pulmonary embolism in dementia patients, study finds
By
Alicia Lasek
Sep 22, 2021
Physicians appear to place lower importance on factors that may lead to diagnosis of pulmonary embolism when evaluating patients with dementia who present with shortness of breath, investigators say.